Journal article
Beta-Lactam and sulfonamide allergy testing should be a standard of care in immunocompromised host
The Journal of Allergy and Clinical Immunology: In Practice, Vol.7(7), pp.2151-2153
2019
Abstract
This work was supported by the Austin Medical Research Foundation. J.A.T. is supported by a National Health and Medical Research Council (NHMRC) postgraduate scholarship (GNT 1139902) and a postgraduate scholarship from the National Centre for Infections in Cancer, NHMRC, Centre for Research Excellence (App 1116876). E.J.P. receives grant support from the National Institutes of Health (award nos. 1P50GM115305-01) and the NHMRC.
Details
- Title
- Beta-Lactam and sulfonamide allergy testing should be a standard of care in immunocompromised host
- Authors/Creators
- J.A. Trubiano (Author/Creator)M.A. Slavin (Author/Creator)K.A. Thursky (Author/Creator)M.L. Grayson (Author/Creator)E.J. Phillips (Author/Creator)
- Publication Details
- The Journal of Allergy and Clinical Immunology: In Practice, Vol.7(7), pp.2151-2153
- Publisher
- Elsevier
- Identifiers
- 991005540190707891
- Copyright
- © 2019 Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
23 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.265 Dermatology - Skin Allergies
- 1.265.1140 Drug Hypersensitivity
- Web Of Science research areas
- Allergy
- Immunology
- ESI research areas
- Clinical Medicine